Chemotherapy or Chemotherapy Plus PD-1 Antibody in RET Fusion Positive Advanced NSCLC Patitnts: the POSEIDON Trial

Clinical trial NCT04322591 · UNKNOWN

Trial details

NCT number: NCT04322591
Sponsor: Hunan Province Tumor Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer

Start date: 2020-03-24
Primary completion: 2024-12-24
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.